Melanoma in the Fire Service - an Occupation We Need to Target for S…

Christine Kannler

Melanoma in Children

Riccardo Pampena

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

Overview of Skin Cancers for General Practitioners

Tarek Haykal

Diagnosing Melanoma: What Patients and Dermatologists Need to Know

Melanoma Research Foundation

J. Litak

Year in Review 2024 - Melanoma

Oncology 2024 Year in Review

A. van Akkooi

Year in Review 2024 - Key Updates in Melanoma Treatment

Oncology 2024 Year in Review

T. Haykal

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

Lynch Syndrome and Skin: A Dermatologist’s Perspective

Dana-Farber Cancer Institute

V. Nambudiri

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Medical Treatments for Melanoma: Current and Future Options

Melanoma Research Foundation

F. Collichio

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

Role of Nivolumab/Relatlimab in the 1L Treatment Landscape for Metas…

Rodabe Amaria

Managing Hyperglycemia During Inavolisib Therapy: Guidelines, Patien…

Doina Catrinoiu

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

Dysplastic Nevi: Navigating the Risk Landscape

Scripps Health

B. Kelley

The Latest and Greatest in Melanoma Treatment, 2024: From Adjuvant t…

Melanoma Research Foundation

K. Margolin